HUNTSMAN CAROLE (Chief Commercial Officer) sold 16.3% of their position (1.96K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.08M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−894.00
Price / share
$550.97
Trade value
$492.57K
% of position
Common Stock
Shares
−144.00
Price / share
$547.27
Trade value
$78.81K
% of position
Common Stock
Shares
−120.00
Price / share
$548.71
Trade value
$65.85K
% of position
Common Stock
Shares
−40.00
Price / share
$549.34
Trade value
$21.97K
% of position
Common Stock
Shares
−200.00
Price / share
$552.38
Trade value
$110.48K
% of position
Common Stock
Shares
−40.00
Price / share
$553.23
Trade value
$22.13K
% of position
Common Stock
Shares
−120.00
Price / share
$556.04
Trade value
$66.72K
% of position
Common Stock
Shares
−200.00
Price / share
$559.60
Trade value
$111.92K
% of position
Common Stock
Shares
−80.00
Price / share
$560.62
Trade value
$44.85K
% of position
Common Stock
Shares
−40.00
Price / share
$563.21
Trade value
$22.53K
% of position
Common Stock
Shares
−80.00
Price / share
$564.57
Trade value
$45.17K
% of position
Net shares
−1.96K
Net value
-$1.08M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2025 | S · Sale | −894.00 | $550.97 | $492.57K | 7.5% | 11.99K | 11.10K |
| Common Stock Direct | 11/21/2025 | S · Sale | −144.00 | $547.27 | $78.81K | 1.3% | 11.10K | 10.95K |
| Common Stock Direct | 11/21/2025 | S · Sale | −120.00 | $548.71 | $65.85K | 1.1% | 10.95K | 10.83K |
| Common Stock Direct | 11/21/2025 | S · Sale | −40.00 | $549.34 | $21.97K | 0.4% | 10.83K | 10.79K |
| Common Stock Direct | 11/21/2025 | S · Sale | −200.00 | $552.38 | $110.48K | 1.9% | 10.79K | 10.59K |
| Common Stock Direct | 11/21/2025 | S · Sale | −40.00 | $553.23 | $22.13K | 0.4% | 10.59K | 10.55K |
| Common Stock Direct | 11/21/2025 | S · Sale | −120.00 | $556.04 | $66.72K | 1.1% | 10.55K | 10.43K |
| Common Stock Direct | 11/21/2025 | S · Sale | −200.00 | $559.60 | $111.92K | 1.9% | 10.43K | 10.23K |
| Common Stock Direct | 11/21/2025 | S · Sale | −80.00 | $560.62 | $44.85K | 0.8% | 10.23K | 10.15K |
| Common Stock Direct | 11/21/2025 | S · Sale | −40.00 | $563.21 | $22.53K | 0.4% | 10.15K | 10.11K |
| Common Stock Direct | 11/21/2025 | S · Sale | −80.00 | $564.57 | $45.17K | 0.8% | 10.11K | 10.03K |
| Total | −1.96K | -$1.08M | ||||||